WallStSmart

Joint Stock Company Kaspi.kz (KSPI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Joint Stock Company Kaspi.kz generates 1406583% more annual revenue ($3.64T vs $258.90M). KSPI leads profitability with a 26.5% profit margin vs -15.5%. KSPI earns a higher WallStSmart Score of 57/100 (C).

KSPI

Buy

57

out of 100

Grade: C

Growth: 7.3Profit: 8.0Value: 6.7Quality: 7.8
Piotroski: 5/9

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for KSPI.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KSPI6 strengths · Avg: 9.7/10
P/E RatioValuation
7.1x10/10

Attractively priced relative to earnings

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
51.2%10/10

Every $100 of equity generates 51 in profit

Revenue GrowthGrowth
52.0%10/10

Revenue surging 52.0% year-over-year

Profit MarginProfitability
26.5%9/10

Keeps 27 of every $100 in revenue as profit

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KSPI3 concerns · Avg: 2.3/10
Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

EPS GrowthGrowth
-9.5%2/10

Earnings declined 9.5%

Free Cash FlowQuality
$-1.38T2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KSPI

The strongest argument for KSPI centers on P/E Ratio, Price/Book, Return on Equity. Profitability is solid with margins at 26.5%. Revenue growth of 52.0% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KSPI

The primary concerns for KSPI are Operating Margin, EPS Growth, Free Cash Flow.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KSPI profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

KSPI is growing revenue faster at 52.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KSPI scores higher overall (57/100 vs 41/100), backed by strong 26.5% margins and 52.0% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Joint Stock Company Kaspi.kz

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Joint Stock Company Kaspi.kz is a prominent fintech and digital services leader in Kazakhstan, renowned for its extensive offerings in digital banking, e-commerce, and payment processing solutions. By utilizing cutting-edge technology, the company enhances financial inclusion, effectively serving millions of customers with personalized services. Positioned strategically in a rapidly growing market, Kaspi.kz is well-equipped to address the increasing demand for digital financial services in Central Asia, presenting a compelling investment opportunity for institutional investors aiming to tap into the growth potential of emerging markets.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?